NIOBRICE
LIVE

Serial Number

79260490

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 8, 2019

Add to watchlist:

No watchlists yet
View on USPTO

NIOBRICE Trademark

Serial Number: 79260490 • Registration: 6661707

NIOBRICE is a trademark filed by NOVARTIS AG on April 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 8, 2019

Registration Date

March 8, 2022

Published for Opposition

December 21, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION PROCESSED BY IB
Jul 17, 2022 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jun 23, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 23, 2022 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 7, 2022 GPAR
REGISTERED-PRINCIPAL REGISTER
Mar 8, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 21, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 21, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 1, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 1, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 1, 2021 NONP
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Nov 17, 2021 CREV
REG. CANCELLED - RESTORED TO PENDENCY
Oct 6, 2021 CRTP
ASSIGNED TO PETITION STAFF
Jul 1, 2021 APET
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Jun 15, 2021 RCII
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2021 APRE
REINSTATED
Apr 27, 2021 REIN
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2021 APRE
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 24, 2021 CRCV
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 2, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 2, 2019 DETH
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2019 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 13, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 13, 2019 REAP
PUBLISHED FOR OPPOSITION
Aug 6, 2019 PUBO
NOTICE OF PUBLICATION
Jul 17, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2019 CNSA
APPLICATION FILING RECEIPT MAILED
Jun 28, 2019 MAFR
ASSIGNED TO EXAMINER
Jun 24, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 17, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 6, 2019 SDRC